Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Neuronetics Inc., 3 years.
Neuronetics Inc.
Director
Anika Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Neuronetics Inc. May 28, 202671.0%
-
Neuronetics Inc. May 22, 202597.9%
-
Anika Therapeutics Inc. July 9, 202496.3%
-
Neuronetics Inc. May 30, 202486.6%
-
Neuronetics Inc. May 25, 202357.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 18, 2026 | Anika Therapeutics Inc. | Grant or award | +10,402 | — | — |
| May 28, 2026 | Neuronetics Inc. | Grant or award | +30,000 | — | — |
| Oct 20, 2025 | Neuronetics Inc. | Grant or award | +7,326 | — | — |
| Jun 20, 2025 | Anika Therapeutics Inc. | Grant or award | +14,164 | — | — |
| May 22, 2025 | Neuronetics Inc. | Grant or award | +30,000 | — | — |
| Feb 7, 2025 | Neuronetics Inc. | Other | +44,444 | $2.25 | $99,999 |
| Jul 9, 2024 | Anika Therapeutics Inc. | Grant or award | +5,771 | — | — |
| May 30, 2024 | Neuronetics Inc. | Grant or award | +25,000 | — | — |
| Jun 14, 2023 | Anika Therapeutics Inc. | Grant or award | +6,500 | — | — |
| May 25, 2023 | Neuronetics Inc. | Grant or award | +36,364 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.